gene therapy - search results

New clinical trials in brain health require innovative methodologies for targeted recruitment and longitudinal assessment. Professor Anne Corbett outlines how her team’s PROTECT portfolio can overcome challenges in trials of cognitive health interventions, offering solutions for intelligent trial design.

Dr Mark Verrill, Consultant Medical Oncologist at the Northern Centre for Cancer Care, discusses the importance of personalised breast cancer treatment.

Jessie R. Badley and Pamela J. Lein from the University of California, Davis, explain the science behind detoxification and the claims of detox health benefits in social media and the deception associated with it.

Neurological diseases are the foremost cause of ill health and disability worldwide. Open Access Government offers an overview of the prevalence of these conditions.

Ashley V. Makela and Christopher H. Contag from the Institute for Quantitative Health Science and Engineering, walk us through watching living therapeutics in action, including what imaging reveals about engineered endosymbionts.

Priya Hays, M.S., Ph.D. is an accomplished science writer Hays has written and published five books as well as having authored over twenty publications in journals as varied as the Bulletin of Science, Technology and Society, L’Esprit Createur, Interdisciplinary Literary Studies, Genetics in Medicine, Journal of Clinical Investigation and Studies,...

In a significant advancement for breast cancer treatment, a new blood test has shown the ability to predict the recurrence of breast cancer up to three years before tumours become detectable through conventional scans.

Dr. Priya Hays, PhD, CEO and Science Writer at Hays Documentation Specialists, LLC, guides us through the world of personalized cancer medicines.

Two seasoned experts from CPI, Medicines Manufacturing Innovation Centre, detail how the “tides” have turned in pharma manufacturing.

Else Marit Inderberg and Sébastien Wälchli from Oslo University Hospital explore what we need to know about T cells successfully fighting cancer.

Sébastien Wälchli obtained his PhD (Tyrosine Phosphatase signaling) at the University of Geneva, Geneva, Switzerland in 2002 and his postdoctoral training (Toxin endocytosis) at the Oslo University Hospital, Oslo, Norway He converted to researcher in cancer immunology (TCR isolation and development) in 2007 and from 2013 became project leader for...

Antonius M. VanDongen, Associate Professor from Duke University, walks us through Arc, a new target for treating Alzheimer’s disease.

Attention-Deficit/Hyperactivity Disorder (ADHD) often displays differently in women compared to men.

Zisis Kozlakidis from the World Health Organization’s International Agency for Cancer and Jiaao Yu from the Shanghai Jiao Tong University discuss the burden of lung cancer in Southeast Asia and China and the priorities for therapies and interventions.

Scientists at Moffitt Cancer Center have revealed a hidden layer of cellular intelligence that questions the traditional understanding of how cells operate.

Find out here about a geriatric psychiatry program at the Music and Mental Health Research Clinic that improves the wellbeing of older adults.

Lorna Rothery spoke to the Cancer Drug Development Forum’s Managing Director, Professor Jaap Verweij and Chairperson of the CDDF Board of Directors, Professor Ruth Plummer, about opportunities and challenges in oncology research and treatment.

We discuss the impact of exercise on mental health and wellbeing with representatives of the American Psychological Association’s Division 47.

Although the use of asbestos-containing building materials was banned in the UK in 1999, this carcinogenic mineral continues to be a serious health threat. Daniel J. Murphy from the University of Glasgow tells us more.

OTC drugs are not harmless. Understanding the effects and dangers of OCT abuse and misuse is key to public safety, here UC Davis explains